BHSC Stock Overview
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally.
BioHarvest Sciences Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.30|
|52 Week High||CA$0.54|
|52 Week Low||CA$0.25|
|1 Month Change||-14.29%|
|3 Month Change||-21.05%|
|1 Year Change||-10.45%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||100.00%|
Recent News & Updates
|BHSC||CA Food||CA Market|
Return vs Industry: BHSC exceeded the Canadian Food industry which returned -25.1% over the past year.
Return vs Market: BHSC underperformed the Canadian Market which returned 5.9% over the past year.
|BHSC Average Weekly Movement||5.1%|
|Food Industry Average Movement||9.0%|
|Market Average Movement||9.7%|
|10% most volatile stocks in CA Market||16.7%|
|10% least volatile stocks in CA Market||4.3%|
Stable Share Price: BHSC is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: BHSC's weekly volatility has decreased from 10% to 5% over the past year.
About the Company
BioHarvest Sciences Inc., together with its subsidiaries, offers nutraceutical super fruits and cannabis verticals in Israel and internationally. Its plant cell growth technology produces the active secondary metabolites without the need to grow the plant itself. The company designs, develops, manufactures, and markets Vinia, a red grape powder nutraceutical product; and medical cannabis.
BioHarvest Sciences Fundamentals Summary
|BHSC fundamental statistics|
Is BHSC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BHSC income statement (TTM)|
|Cost of Revenue||US$1.43m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.022|
|Net Profit Margin||-467.51%|
How did BHSC perform over the long term?See historical performance and comparison
Is BioHarvest Sciences undervalued compared to its fair value and its price relative to the market?
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate BHSC's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate BHSC's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: BHSC is unprofitable, so we can't compare its PE Ratio to the Canadian Food industry average.
PE vs Market: BHSC is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate BHSC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: BHSC is overvalued based on its PB Ratio (37.2x) compared to the CA Food industry average (1.9x).
How is BioHarvest Sciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Food, Beverage & Tobacco industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BioHarvest Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has BioHarvest Sciences performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: BHSC is currently unprofitable.
Growing Profit Margin: BHSC is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: BHSC is unprofitable, and losses have increased over the past 5 years at a rate of 25% per year.
Accelerating Growth: Unable to compare BHSC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BHSC is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (-22.1%).
Return on Equity
High ROE: BHSC has a negative Return on Equity (-344.2%), as it is currently unprofitable.
How is BioHarvest Sciences's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: BHSC's short term assets ($5.7M) exceed its short term liabilities ($2.9M).
Long Term Liabilities: BHSC's short term assets ($5.7M) exceed its long term liabilities ($4.4M).
Debt to Equity History and Analysis
Debt Level: BHSC is debt free.
Reducing Debt: BHSC had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BHSC has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BHSC is forecast to have sufficient cash runway for 4 months based on free cash flow estimates, but has since raised additional capital.
What is BioHarvest Sciences's current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate BHSC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BHSC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if BHSC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BHSC's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BHSC has not reported any payouts.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Ilan Sobel has been the Chief Executive Officer at BioHarvest Sciences Inc. since June 9, 2020. He served as Chief Operating Officer at Weissbeerger Ltd. and then Chief Commercial Officer of Weissbeerg...
Experienced Management: BHSC's management team is considered experienced (2.8 years average tenure).
Experienced Board: BHSC's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.3%.
BioHarvest Sciences Inc.'s employee growth, exchange listings and data sources
- Name: BioHarvest Sciences Inc.
- Ticker: BHSC
- Exchange: CNSX
- Founded: NaN
- Industry: Packaged Foods and Meats
- Sector: Food, Beverage & Tobacco
- Implied Market Cap: CA$136.254m
- Shares outstanding: 454.18m
- Website: https://www.bioharvest.com
Number of Employees
- BioHarvest Sciences Inc.
- 1140-625 Howe Street
- British Columbia
- V6C 2T6
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/18 00:00|
|End of Day Share Price||2022/05/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.